From July 5 to 6, 2025, the 2025 International Digestive Disease Forum (IDDF) was successfully held at the Hong Kong Convention and Exhibition Centre, bringing together leading experts and scholars from around the world in the fields of digestive diseases and gut microbiome research to discuss the latest advances in cutting-edge technologies and clinical translation.
As a domestic high-tech enterprise specializing in germ-free animal research services, Gnotobio Biotechnology was invited to exhibit for the second time, showcasing its core products and multiple innovative technologies, and comprehensively demonstrating the unique value of germ-free animals in gut microbiome and digestive disease research.
At this exhibition, Gnotobio Biotechnology highlighted the following:
● Self-bred germ-free animal strains (C57BL/6J, BALB/c, ApoE, APCMin/+)
● Personalized Disease Model Construction
● Humanized Microbiota Transplantation and Evaluation Services
● Advanced Experimental Evaluation System for Gut Microbiota in Germ-Free Animals
● Comprehensive Quality Control and Testing System
From sterile isolator housing and routine pathogen testing to environmental monitoring, Gnotobio Biotechnology strictly adheres to SOP procedures that exceed industry standards, ensuring the absolute sterility of experimental animals and high reproducibility of data.
Looking ahead, Gnotobio Biotechnology will continue to leverage its core technologies and international research team to deepen its focus on germ-free animal and microbiome research, helping to unravel the complex links between gut microbiota and diseases, and advancing the clinical translation of microbiome drug development and personalized therapeutic solutions.
We look forward to collaborating with more research partners and clinical experts to achieve further breakthroughs in digestive disease and microbiome research, jointly writing a new chapter for human health.